These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23559710)
21. The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma. Yamaguchi S; Hirata K; Kobayashi H; Shiga T; Manabe O; Kobayashi K; Motegi H; Terasaka S; Houkin K Ann Nucl Med; 2014 Aug; 28(7):603-9. PubMed ID: 24743915 [TBL] [Abstract][Full Text] [Related]
22. Dual-time point Parghane RV; Basu S Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277 [TBL] [Abstract][Full Text] [Related]
23. The Role of Dual-Phase FDG PET/CT in the Diagnosis and Follow-Up of Brain Tumors. Özütemiz C; Neil EC; Tanwar M; Rubin NT; Ozturk K; Cayci Z AJR Am J Roentgenol; 2020 Oct; 215(4):985-996. PubMed ID: 32841063 [No Abstract] [Full Text] [Related]
24. A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors. Sharma R; D'Souza M; Jaimini A; Hazari PP; Saw S; Pandey S; Singh D; Solanki Y; Kumar N; Mishra AK; Mondal A Indian J Nucl Med; 2016; 31(2):93-102. PubMed ID: 27095856 [TBL] [Abstract][Full Text] [Related]
25. Metabolic changes in breast cancer on dual-time-point Kim HO; Kim BS; Kang SY; Bang JI; An J; Kim JH; Yoon HJ Ann Nucl Med; 2020 Dec; 34(12):942-951. PubMed ID: 32974848 [TBL] [Abstract][Full Text] [Related]
26. Semi-quantitative analysis of Ravikanth R; Singh JK World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503 [No Abstract] [Full Text] [Related]
27. Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes. Nozawa A; Rivandi AH; Kanematsu M; Hoshi H; Piccioni D; Kesari S; Hoh CK Nucl Med Commun; 2015 Jun; 36(6):573-81. PubMed ID: 25714806 [TBL] [Abstract][Full Text] [Related]
28. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584 [TBL] [Abstract][Full Text] [Related]
29. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166 [TBL] [Abstract][Full Text] [Related]
30. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors. Komek H; Can C; Urakçi Z; Kepenek F Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875 [TBL] [Abstract][Full Text] [Related]
31. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
32. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors. Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
34. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494 [TBL] [Abstract][Full Text] [Related]
35. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458 [TBL] [Abstract][Full Text] [Related]